Akèy › Limfòm folikilè › Iowa › Des Moines
Etid klinik pou Limfòm folikilè nan Des Moines, IA
4 etid pou Limfòm folikilè ap chèche patisipan nan sit nan ak bò kote Des Moines (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Ap rekriteFaz 3
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Broadlawns Medical Center, Des Moines
- ak 5 plis
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Ap rekriteFaz 3
- Research Site, Des Moines
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Ap rekriteFaz 2
- Research Site, Waukee · 14 mi lwen
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Ap rekriteFaz 3
- Local Institution - 0243, Waukee · 14 mi lwen
Etid Limfòm folikilè nan lòt vil
- New York City, NY24 etid
- Milwaukee, WI19 etid
- Nashville, TN18 etid
- Houston, TX18 etid
- Boston, MA17 etid
- Baldwin Park, CA16 etid
- Seattle, WA15 etid
- Durham, NC15 etid
- Columbus, OH13 etid
- Salt Lake City, UT13 etid
- San Antonio, TX12 etid
- Chicago, IL12 etid
Lòt etid nan Des Moines
- Kansè Poumon ki pa ti selil11 etid
- Kansè poumon10 etid
- Kansè kolorektal8 etid
- Lukemi lenfositè kwonik8 etid
- Kansè nan tete8 etid
- Sipwa6 etid
- Kansè vejik6 etid
- Kansè pwostat5 etid
- Myelom Miltip5 etid
- Melanom5 etid
- Maladi kadyovaskilè5 etid
- Obèsite5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.